French food group Danone plans to double its nutrition unit's sales in India in the next three years, a company executive said, as the world's top yogurt maker raises its focus on emerging markets to drive growth when its traditional European markets are slowing.
Danone early this year paid about Rs 2,000 crore to buy Indian drugmaker Wockhardt's nutrition business that sells popular brands such as Dexolac, Farex and Nusobee. The brands compete with Danone's top global rival Nestle .
"India's growth in the nutrition sector will outpace China's (growth)," Laurent Marcel, managing director at Danone's India nutrition business unit, told reporters on Thursday. "We are here to expand."
India's baby nutrition market is valued about Rs 2,500 crore, in which Danone holds about 8 percent share, he said.